A New Way to Treat Colon Cancer?

Researchers at University of Utah’s Huntsman Cancer Institute have discovered a new target for possible future colon cancer treatments - a molecule that is implicated in 85 percent of colon cancer cases.

These findings were published online Oct. 6, 2006, in the Journal of Biological Chemistry.

By knocking out - that is, genetically disabling - a molecule called C-Terminal Binding Protein (CTBP) researchers were able to rescue zebrafish from the effects of a mutation in the adenomatous polyposis coli (APC) gene.

In humans, mutations in this gene long have been known to initiate a series of events that cause colon polyps, which eventually become cancerous. APC mutations play a role in 85 percent of colon cancers. The new findings mean CTBP also is involved in that proportion of colon cancers.

In zebrafish, APC mutations keep the intestine from developing properly. “In essence, knocking out CTPB promotes normal development of the intestine in zebrafish carrying an APC mutation,” says David A. Jones, a University of Utah associate professor of oncological sciences and leader of the study.

In normal cells of both humans and zebrafish, the APC gene controls the amount of CTBP present by marking it for destruction. In tumor cells with mutated APC, CTPB is not destroyed; instead it accumulates in the cell.

One function of CTBP is to turn off the process that converts vitamin A into retinoic acid in the cell. Retinoic acid is essential in cell differentiation - the function that determines what type of cell forms and how long it lives. This study observed that in both zebrafish and human tissues with APC mutations, there are high CTBP levels and low capability to produce retinoic acid. In APC-mutated tissues in which CTBP had been “knocked out,” retinoic acid production was restored.

Earlier studies in Jones’ lab showed that lack of retinoic acid caused zebrafish intestines to form incorrectly, and that adding retinoic acid corrected the problems.

“Knocking out CTBP does exactly the same thing, and the logical conclusion is that it’s because CTBP controls retinoic acid production,” says Jones. “Since CTBP is a completely new target, we must now look for potential chemical agents that would work to block its actions. That could take three to five years.”

Other Huntsman Cancer Institute researchers participating in this study include Lincoln D. Nadauld, Reid Phelps, Brent C. Moore, Annie Eisinger, Imelda T. Sandoval, Stephanie Chidester, Peter W. Peterson, Elizabeth J. Manos, Bradford Sklow, and Randall W. Burt.

Funding for this study was provided by the National Cancer Institute and the Huntsman Cancer Foundation.

About colorectal cancer

Colorectal cancer is the second leading cause of cancer deaths in the United States. In 2006, the American Cancer Society estimates that 106,680 cases of colorectal cancer will be diagnosed in the nation, with 700 cases in Utah. Colorectal cancer is the third most common cancer in the United States and Utah.

RELATED STORIES:
How Diarrheal Bacteria Cause Some Colon Cancers   US cancer deaths down but far too few Americans screened for colon cancer   Water method for unsedated colonoscopy; interval between prep and colonoscopy predicts prep quality   Magnesium may curb colon cancer risk in women   Surgery Not Necessary for Most Late-Stage Colorectal Cancers   Negative screening colonoscopy need not be repeated   Some Early Stage Colon Cancer Patients Should Not Receive Chemotherapy   Discovery of a novel mechanism for the development of colon cancer   Sex, Age and Ethnicity Associated With Colorectal Cancer Survival   Fish Oil Protects Against Colon Cancer   Women require less tobacco exposure than men to increase colon cancer risk   Hormone Therapy Offers Potential Protective Effect Against Colon Cancer In Older Women   Experimental drug slows tumor growth   Lifestyle Changes Would Lead to Sharp Drop in Colorectal Cancers   Doctors fail to recommend colon cancer tests for low-income patients   Where one lives impacts colon cancer survival   Can a Mediterranean Diet Help Prevent Colon Cancer?   Tips to Lower Risk of Colorectal Cancer; New Combined Colonoscopy Procedure Avoids Major Surgery   Genetic Link Uncovered in Disparate Colon Cancer Death   Racial gap in colon cancer diagnosis, treatment   Colorectal cancer risk appears unaffected by coffee   Study confirms red meat link with bowel cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]